litlas
ログインアカウント作成

Tetsuya Mitsudomi

1989–2025 年に発表

218
論文数
57,916
被引用数
114
h 指数
214
i10 指数

被引用数

Tetsuya Mitsudomi の年別被引用数1963 年: 被引用 1 件1971 年: 被引用 4 件1989 年: 被引用 1 件1990 年: 被引用 3 件1991 年: 被引用 24 件1992 年: 被引用 63 件1993 年: 被引用 79 件1994 年: 被引用 78 件1995 年: 被引用 69 件1996 年: 被引用 57 件1997 年: 被引用 68 件1998 年: 被引用 71 件1999 年: 被引用 112 件2000 年: 被引用 115 件2001 年: 被引用 121 件2002 年: 被引用 153 件2003 年: 被引用 104 件2004 年: 被引用 129 件2005 年: 被引用 197 件2006 年: 被引用 273 件2007 年: 被引用 323 件2008 年: 被引用 433 件2009 年: 被引用 456 件2010 年: 被引用 489 件2011 年: 被引用 602 件2012 年: 被引用 609 件2013 年: 被引用 661 件2014 年: 被引用 519 件2015 年: 被引用 526 件2016 年: 被引用 459 件2017 年: 被引用 434 件2018 年: 被引用 476 件2019 年: 被引用 1,414 件2020 年: 被引用 1,377 件2021 年: 被引用 1,297 件2022 年: 被引用 1,158 件2023 年: 被引用 1,050 件2024 年: 被引用 1,837 件2025 年: 被引用 858 件2026 年: 被引用 23 件1964〜1970 年は被引用が無いため表示していません1972〜1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,908 件、この内訳の 25.5%中国: 引用元論文 3,012 件、この内訳の 15.6%日本: 引用元論文 1,695 件、この内訳の 8.8%イタリア: 引用元論文 961 件、この内訳の 5%イギリス: 引用元論文 836 件、この内訳の 4.3%ドイツ: 引用元論文 683 件、この内訳の 3.5%韓国: 引用元論文 626 件、この内訳の 3.3%フランス: 引用元論文 622 件、この内訳の 3.2%スペイン: 引用元論文 582 件、この内訳の 3%カナダ: 引用元論文 521 件、この内訳の 2.7%オランダ: 引用元論文 418 件、この内訳の 2.2%台湾: 引用元論文 410 件、この内訳の 2.1%
0%25.5%その他 20.8%

機関

分野

  • Medicine68%
  • Biochemistry, Genetics and Molecular Biology26.7%
  • Immunology and Microbiology2.2%
  • Computer Science0.9%
  • Engineering0.5%
  • Chemistry0.4%
  • その他1.3%

トピック

  • Lung Cancer Treatments and Mutations14.4%
  • Lung Cancer Diagnosis and Treatment8.1%
  • Lung Cancer Research Studies6%
  • Cancer Immunotherapy and Biomarkers4.1%
  • Cancer Genomics and Diagnostics3.8%
  • MicroRNA in disease regulation2.9%
  • その他60.7%

共著者

全論文

検索で開く
  1. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

    著者: Patrick M. Forde, Jonathan Spicer, Shun Lu, Mariano Provencio, Tetsuya Mitsudomi, Mark M. Awad, Enriqueta Felip, Stephen R. Broderick, Julie R. Brahmer, Scott J. Swanson, Keith Kerr, Changli Wang, Tudor-Eliade Ciuleanu, Gene B. Saylors, Fumihiro Tanaka, Hiroyuki Ito, Ke-Neng Chen, Moishe Liberman, Everett E. Vokes, Janis M. Taube, Cecile Dorange, Junliang Cai, Joseph Fiore, Anthony Jarkowski, David Balli, Mark Sausen, Dimple Pandya, Christophe Y. Calvet, Nicolas Girard - New England Journal of Medicine 2022 被引用: 2,558

  2. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

    著者: Hisashi Saji, Morihito Okada, Masahiro Tsuboi, Ryu Nakajima, Kenji Suzuki, Keiju Aokage, Tadashi Aoki, Jiro Okami, Ichiro Yoshino, Hiroyuki Ito, Norihito Okumura, Masafumi Yamaguchi, Norihiko Ikeda, Masashi Wakabayashi, Kenichi Nakamura, Haruhiko Fukuda, Shinichiro Nakamura, Tetsuya Mitsudomi, Shun‐ichi Watanabe, Hisao Asamura - The Lancet 2022 被引用: 1,657

  3. Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

    著者: John V. Heymach, David H. Harpole, Tetsuya Mitsudomi, Janis M. Taube, Gabriella Gálffy, Maximilian J. Hochmair, Thomas Winder, Р. А. Зуков, Gabriel Garbaos, Shugeng Gao, Hiroaki Kuroda, Gyula Ostoros, Tho V. Tran, Jian You, Kang‐Yun Lee, Lorenzo Antonuzzo, Zsolt Pápai-Székely, Hiroaki Akamatsu, Bivas Biswas, Alexander I. Spira, Jeffrey Crawford, Ha Le, Mike Aperghis, Gary J. Doherty, Helen Mann, Tamer M. Fouad, Martin Reck - New England Journal of Medicine 2023 被引用: 682

  4. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    著者: William D. Travis, Élisabeth Brambilla, Masayuki Noguchi, Andrew G. Nicholson, Kim R. Geisinger, Yasushi Yatabe, David G. Beer, Charles A. Powell, Gregory J. Riely, Paul E. Van Schil, Kavita Garg, John H. M. Austin, Hisao Asamura, Valerie W. Rusch, Fred R. Hirsch, Giorgio V. Scagliotti, Tetsuya Mitsudomi, Rudolf M. Huber, Yuichi Ishikawa, James R. Jett, Montse Sánchez‐Céspedes, Jean‐Paul Sculier, Takashi Takahashi, Masahiro Tsuboi, Johan Vansteenkiste, Ignacio I. Wistuba, Pan‐Chyr Yang, Denise R. Aberle, Christian Brambilla, Douglas B. Flieder, Wilbur A. Franklin, Adi F. Gazdar, Michael K. Gould, P S Hasleton, Douglas W. Henderson, Bruce Johnson, David Johnson, Keith M. Kerr, Keiko Kuriyama, Jin Soo Lee, Vincent A. Miller, Iver Petersen, Victor L. Roggli, Rafael Rosell, Nagahiro Saijo, Erik Thunnissen, Ming‐Sound Tsao, David Yankelewitz - Journal of Thoracic Oncology 2011 被引用: 4,843

  5. Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

    著者: Christian Rolfo, Philip C. Mack, Giorgio V. Scagliotti, Charu Aggarwal, Maria E. Arcila, Fabrice Barlési, Trever G. Bivona, Maximilian Diehn, Caroline Dive, Rafał Dziadziuszko, Natasha B. Leighl, Umberto Malapelle, Tony Mok, Nir Peled, Luis E. Raez, Lecia V. Sequist, Lynette M. Sholl, Charles Swanton, Chris Abbosh, Daniel S.W. Tan, Heather A. Wakelee, Ignacio I. Wistuba, Rebecca A. Bunn, Janet Freeman‐Daily, Murry W. Wynes, Chandra P. Belani, Tetsuya Mitsudomi, David R. Gandara - Journal of Thoracic Oncology 2021 被引用: 645

  6. MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

    著者: Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, Youngchul Song, Courtney Hyland, Joon Oh Park, Neal I. Lindeman, Christopher-Michael Gale, Xiao‐Jun Zhao, James G. Christensen, Takayuki Kosaka, Alison J. Holmes, Andrew M. Rogers, Federico Cappuzzo, Tony Mok, Charles Lee, Bruce E. Johnson, Lewis C. Cantley, Pasi A. Jänne - Science 2007 被引用: 4,485

  7. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

    著者: Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, Shunichi Negoro, Isamu Okamoto, Junji Tsurutani, Takashi Seto, Miyako Satouchi, Hirohito Tada, Tomonori Hirashima, Kazuhiro Asami, Nobuyuki Katakami, Minoru Takada, Hiroshige Yoshioka, Kazuhiko Shibata, Shinzoh Kudoh, Eiji Shimizu, Hiroshi Saito, Shinichi Toyooka, Kazuhiko Nakagawa, Masahiro Fukuoka - The Lancet Oncology 2009 被引用: 4,114

  8. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    著者: William D. Travis, Sanja Đačić, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli, Lukas Bubendorf, Paul A. Bunn, Tina Cascone, Jamie E. Chaft, Gang Chen, Teh‐Ying Chou, Wendy A. Cooper, Jeremy J. Erasmus, Carlos Gil Ferreira, Jin-Mo Goo, John V. Heymach, Fred R. Hirsch, Hidehito Horinouchi, Keith M. Kerr, Mark G. Kris, Deepali Jain, Young Tae Kim, Fernando López‐Ríos, Shun Lü, Tetsuya Mitsudomi, André Moreira, Noriko Motoi, Andrew G. Nicholson, Ricardo Oliveira, Mauro Papotti, Ugo Pastorino, Luis Paz‐Ares, Giuseppe Pelosi, Claudia Poleri, Mariano Provencio, Anja C. Roden, Giorgio V. Scagliotti, Stephen G. Swisher, Erik Thunnissen, Ming‐Sound Tsao, Johan Vansteenkiste, Walter Weder, Yasushi Yatabe - Journal of Thoracic Oncology 2020 被引用: 450

  9. KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments

    著者: T. Koga, Kenichi Suda, Toshio Fujino, Shuta Ohara, Akira Hamada, Masaya Nishino, Masato Chiba, Masaki Shimoji, Toshiki Takemoto, Takeo Arita, Michael Gmachl, Marco H. Hofmann, Junichi Soh, Tetsuya Mitsudomi - Journal of Thoracic Oncology 2021 被引用: 251

  10. Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial

    著者: Toyoaki Hida, Hiroshi Nokihara, Masashi Kondo, Young Hak Kim, Koichi Azuma, Takashi Seto, Yuichi Takiguchi, Makoto Nishio, Hiroshige Yoshioka, Fumio Imamura, Katsuyuki Hotta, Satoshi Watanabe, Kōichi Goto, Miyako Satouchi, Toshiyuki Kozuki, Takehito Shukuya, Kazuhiko Nakagawa, Tetsuya Mitsudomi, Nobuyuki Yamamoto, T. Asakawa, Ryoichi Asabe, Tomohiro Tanaka, Tomohide Tamura - The Lancet 2017 被引用: 912

  11. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer

    著者: Kenji Suzuki, Shun‐ichi Watanabe, Masashi Wakabayashi, Hisashi Saji, Keiju Aokage, Yasumitsu Moriya, Ichiro Yoshino, Masahiro Tsuboi, Shinichiro Nakamura, Kenichi Nakamura, Tetsuya Mitsudomi, Hisao Asamura - Journal of Thoracic and Cardiovascular Surgery 2020 被引用: 381

  12. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Johan Vansteenkiste, Byoung Chul Cho, Tõnu Vanakesa, Tommaso De Pas, M. Zieliński, Moon Soo Kim, Jacek Jassem, Masahiro Yoshimura, Jubrail Dahabreh, Haruhiku Nakayama, Libor Havel, Haruhiko Kondo, Tetsuya Mitsudomi, Paul Zarogoulidis, Oleg Gladkov, Katalin Udud, Hirohito Tada, Hans Hoffman, Anders Bugge, Paul Taylor, Emilio Esteban Gonzalez, Mei Lin Liao, Jianxing He, Jean-Louis Pujol, Jamila Louahed, Muriel Debois, Vincent Brichard, C. Debruyne, Patrick Therasse, Nasser K. Altorki - The Lancet Oncology 2016 被引用: 497

  13. Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies

    著者: Melissa L. Johnson, Marina Chiara Garassino, Tony Mok, Tetsuya Mitsudomi - Lung Cancer 2022 被引用: 150

  14. Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study

    著者: Glenwood Goss, Chun‐Ming Tsai, Frances A. Shepherd, Lyudmila Bazhenova, Jong Seok Lee, Gee‐Chen Chang, Lucio Crinò, Miyako Satouchi, Quincy S. Chu, Toyoaki Hida, Ji‐Youn Han, Óscar Juan, Frank Dunphy, Makoto Nishio, Jin‐Hyoung Kang, Margarita Majem, Helen Mann, Mireille Cantarini, Serban Ghiorghiu, Tetsuya Mitsudomi - The Lancet Oncology 2016 被引用: 643

  15. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial

    著者: Keiju Aokage, Kenji Suzuki, Hisashi Saji, Masashi Wakabayashi, Tomoko Kataoka, Yuta Sekino, Haruhiko Fukuda, Makoto Endo, Aritoshi Hattori, Takahiro Mimae, Tomohiro Miyoshi, Mitsuhiro Isaka, Hiroshige Yoshioka, Ryu Nakajima, Kazuo Nakagawa, Jiro Okami, Hiroyuki Ito, Hiroaki Kuroda, Masahiro Tsuboi, Norihito Okumura, Makoto Takahama, Yasuhisa Ohde, Tadashi Aoki, Yasuhiro Tsutani, Morihito Okada, Shun‐ichi Watanabe, Yukinori Sakao, Sakae Okumura, Toshihiko Iizasa, Ichiro Yoshino, Atsushi Fujita, Morihito Okada, Masahiro Yoshimura, Yuji Asato, Kenji Suzuki, Haruhiko Nakayama, Isao Matsumoto, Tetsuya Mitsudomi, Takashi Marutsuka, Makoto Suzuki, Norihito Okumura, Haruhiko Kondo, Hiroshi Date, Takeshi Nagayasu, Kohei Yokoi, Shunichi Watanabe, Masahiro Tsuboi, Akihide Matsumura, Yoshinori Yamashita, Kiyoshi Ishikawa, Motohiro Yamashita, Yasuki Saito, Mitsuhiro Takenoyama, Katsuo Yoshiya, Kenji Sugio, Shinichiro Miyoshi, Makoto Takahama, Yoshihisa Kadota, Masahiko Higashiyama, Meinoshin Okumura, Hirohiko Akiyama, Akinori Iwasaki, Yasuhisa Ohde, Haruhiko Nakamura, Haruhisa Matsuguma, Takashi Kondo, Norihiko Ikeda, Hirotoshi Horio, Toru Sato, Takuya Nagashima, Akira Yoshizu, Hiromi Katsuki, Hiroaki Kuroda, Mingyon Mun, Kouhei Tajima, Wataru Nishio, Moriyuki Kiyoshima, Hiroyuki Ito, Yasuhiro Tsutani, Masashi Kobayashi, Masaki Anraku, Toyofumi Yoshikawa, Hyung-eun Yoon, Takeshi Mimura, Tsutomu Kawabata, Tohru Hasumi, Tatsuro Okamoto, Tadashi Aoki, Shinichi Toyooka, Jiro Okami, Yasushi Shintani, Tomomi Hirata, Hisashi Saji, Yoshinori Okada, Makoto Endo, Tetsukan Woo, Mai Daido - The Lancet Respiratory Medicine 2023 被引用: 227

  16. A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)

    著者: Kenji Suzuki, Teruaki Koike, T. Asakawa, Masahiko Kusumoto, Hisao Asamura, Kanji Nagai, Hirohito Tada, Tetsuya Mitsudomi, Masahiro Tsuboi, Taro Shibata, Haruhiko Fukuda, Harubumi Kato - Journal of Thoracic Oncology 2011 被引用: 657

  17. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

    著者: Antonio Passaro, Natasha B. Leighl, Fiona Blackhall, Sanjay Popat, Keith M. Kerr, Myung‐Ju Ahn, Maria E. Arcila, Óscar Arrieta, David Planchard, Filippo de Marinis, Anne‐Marie C. Dingemans, Rafał Dziadziuszko, Corinne Faivre‐Finn, Jill Feldman, Enriqueta Felip, Giuseppe Curigliano, Roy S. Herbst, Pasi A. Jänne, Thomas John, Tetsuya Mitsudomi, Tony Mok, Nicola Normanno, Luis Paz‐Ares, Suresh S. Ramalingam, Lecia V. Sequist, Johan Vansteenkiste, Ignacio I. Wistuba, Juergen Wolf, Yi‐Long Wu, Sihai Yang⧫, James Chih‐Hsin Yang, Yasushi Yatabe, George Pentheroudakis, Solange Peters - Annals of Oncology 2022 被引用: 190

  18. Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy

    著者: Yoshihisa Kobayashi, Tetsuya Mitsudomi - Cancer Science 2016 被引用: 413

  19. BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer

    著者: Sun Min Lim, Toshio Fujino, Chulwon Kim, Gwanghee Lee, Yong-Hee Lee, Dong‐Wan Kim, Jin Seok Ahn, Tetsuya Mitsudomi, Taiguang Jin, Sang-Yoon Lee - Clinical Cancer Research 2023 被引用: 72

  20. Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer

    著者: Jonathan Spicer, Tina Cascone, Murry W. Wynes, Myung-Ju Ahn, Sanja Đačić, Enriqueta Felip, Patrick M. Forde, Kristin A. Higgins, Mark G. Kris, Tetsuya Mitsudomi, Mariano Provencio, Suresh Senan, Benjamin Solomon, Ming‐Sound Tsao, Masahiro Tsuboi, Heather A. Wakelee, Yi-Long Wu, James C. Yang, Caicun Zhou, David H. Harpole, Karen Kelly - Journal of Thoracic Oncology 2024 被引用: 129

  21. Consensus for HER2 alterations testing in non-small-cell lung cancer

    著者: Shengxiang Ren, Jiong Wang, Jianming Ying, Tetsuya Mitsudomi, Daniel Lee, Zengwu Wang, Q. Chu, Philip C. Mack, Ying Cheng, Jianchun Duan, Yun Fan, Baohui Han, Zhouguang Hui, A. Liu, Jing Liu, You Lü, Z. Ma, Meiqi Shi, Yongqian Shu, Qibin Song, Xia Song, Yong Song, C. Wang, X. Wang, Zhaoguang Wang, Yi Xu, Yu Yao, L. Zhang, Mingfang Zhao, Bo Zhu, Jun Zhang, Caicun Zhou, Fred R. Hirsch - ESMO Open 2022 被引用: 111

  22. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer

    著者: Tetsuya Mitsudomi, Yasushi Yatabe - FEBS Journal 2009 被引用: 565

  23. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

    著者: Junichi Takamizawa, Hiroyuki Konishi, Kiyoshi Yanagisawa, Shuta Tomida, Hirotaka Osada, Hideki Endoh, Tomoko Harano, Yasushi Yatabe, Masato Nagino, Yuji Nimura, Tetsuya Mitsudomi, Takashi Takahashi - Cancer Research 2004 被引用: 2,359

  24. Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non–Small-Cell Lung Cancer With EGFR Mutation (IMPACT)

    著者: Hirohito Tada, Tetsuya Mitsudomi, Toshihiro Misumi, Kenji Sugio, Masahiro Tsuboi, Isamu Okamoto, Yasuo Iwamoto, Noriaki Sakakura, Shunichi Sugawara, Shinji Atagi, Toshiaki Takahashi, Hidetoshi Hayashi, Morihito Okada, Hidetoshi Inokawa, Hiroshige Yoshioka, Kazuhisa Takahashi, Masahiko Higashiyama, Ichiro Yoshino, Kazuhiko Nakagawa, for the West Japan Oncology Group - Journal of Clinical Oncology 2021 被引用: 143